Treatment of relapsed Wilms tumour (WT) patients: Experience with topotecan. A report from the SIOP Renal Tumour Study Group (RTSG)

Keyphrases

• Wilms Tumor 100%
• Tumor Patients 100%
• Renal Tumor 100%
• Tumor Research 100%
• Patient Experience 100%
• Topotecan 100%
• Intermediate Risk 30%
• Histology 30%
• High Risk Histology 20%
• Progressive Disease 20%
• Initial Treatment 10%
• Clinical High Risk 10%
• Initial Diagnosis 10%
• Effective Compounds 10%
• Patient Characteristics 10%
• Patient Charts 10%
• Objective Response 10%
• Partial Response 10%
• Treatment Schedule 10%
• Response to Treatment 10%
• Salvage Treatment 10%
• Chemotherapeutic Regimens 10%
• Salvage Regimen 10%
• Toxicity Response 10%
• General Patients 10%
• Bilateral Nephrectomy 10%
• Primary Progressive 10%

Medicine and Dentistry

• Wilms' Tumor 100%
• Kidney Tumour 100%
• Patient Experience 100%
• Topotecan 100%
• Progressive Disease 20%
• Patient with Wilms' Tumor 10%
• Retrospective Study 10%
• Patient Characteristics 10%
• Bilateral Nephrectomy 10%